Hrusak O - Search Results

1

The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells.

Starkova J, Madzo J, Cario G, Kalina T, Ford A, Zaliova M, Hrusak O, Trka J. Starkova J, et al. Among authors: hrusak o. Clin Cancer Res. 2007 Mar 15;13(6):1726-35. doi: 10.1158/1078-0432.CCR-06-2569. Epub 2007 Feb 26. Clin Cancer Res. 2007. PMID: 17325341 Free article.

2

Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Pediatric Hematology Working Group in Czech Republic.

Trka J, Zuna J, Hrusák O, Kalinová M, Muzíková K, Lauschman H, Starý J. Trka J, et al. Among authors: hrusak o. Leukemia. 1998 Jun;12(6):996-7. doi: 10.1038/sj.leu.2401052. Leukemia. 1998. PMID: 9639432 No abstract available.

3

Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic.

Hrusák O, Trka J, Zuna J, Housková J, Bartůnková J, Starý J. Hrusák O, et al. Leukemia. 1998 Jul;12(7):1064-70. doi: 10.1038/sj.leu.2401072. Leukemia. 1998. PMID: 9665191

4

TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group.

Zuna J, Hrusák O, Kalinová M, Muzíková K, Starý J, Trka J. Zuna J, et al. Among authors: hrusak o. Leukemia. 1999 Jan;13(1):22-4. doi: 10.1038/sj.leu.2401256. Leukemia. 1999. PMID: 10049055

5

Are we ready to curtail testing for TEL/AML1 fusion? Pediatric Hematology Working Group in the Czech Republic.

Hrusák O, Trka J, Zuna J, Bartůnková J, Starý J. Hrusák O, et al. Leukemia. 1999 Jun;13(6):981-3. doi: 10.1038/sj.leu.2401403. Leukemia. 1999. PMID: 10360390 No abstract available.

6

[Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].

Trka J, Zuna J, Haskovec C, Brabencová A, Kalinová M, Muzíková K, Paukertová R, Hrusák O, Zemanová Z, Michalová K, Starý J. Trka J, et al. Among authors: hrusak o. Cas Lek Cesk. 1999 Jan 4;138(1):12-7. Cas Lek Cesk. 1999. PMID: 10953429 Czech.

7

Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.

Sedlácek P, Trka J, Zuna J, Hrusák O, Honzátková-Krsková L, Stary J. Sedlácek P, et al. Among authors: hrusak o. Haematologica. 2000 Oct;85(10):1100-2. Haematologica. 2000. PMID: 11025608 No abstract available.

8

[Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia].

Zuna J, Hrusák O, Kalinová M, Muzíková K, Zörnerová T, Starý J, Trka J. Zuna J, et al. Among authors: hrusak o. Vnitr Lek. 2000 Aug;46(8):465-9. Vnitr Lek. 2000. PMID: 11048511 Czech.

9

Acute lymphoblastic leukemia incidence during socioeconomic transition: selective increase in children from 1 to 4 years.

Hrusák O, Trka J, Zuna J, Poloucková A, Kalina T, Starý J; Czech Pediatric Hematology Working Group. Hrusák O, et al. Leukemia. 2002 Apr;16(4):720-5. doi: 10.1038/sj.leu.2402422. Leukemia. 2002. PMID: 11960355

10

Significance of real-time quantitative PCR detection of p16 gene deletions in childhood acute lymphoblastic leukemia.

Zuna J, Muzikova K, Hrusak O, Stary J, Trka J. Zuna J, et al. Among authors: hrusak o. Haematologica. 2002 Jun;87(6):668-9. Haematologica. 2002. PMID: 12031930 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters